A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants

S Halvorsen, W Ghanima, I Fride Tvete… - European Heart …, 2017 - academic.oup.com
Aims We aimed to evaluate bleeding risk in clinical practice in patients with atrial fibrillation
(AF) being prescribed dabigatran, rivaroxaban, or apixaban compared with warfarin …
被引用次数：149 相关文章

A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants.

S Halvorsen, W Ghanima, F Tvete… - European Heart …, 2016 - europepmc.org
Aims We aimed to evaluate bleeding risk in clinical practice in patients with atrial fibrillation
(AF) being prescribed dabigatran, rivaroxaban, or apixaban compared with warfarin …

[引用][C] A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants

S Halvorsen, W Ghanima, IF Tvete, C Hoxmark… - European Heart …, 2016 - cir.nii.ac.jp
A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being
prescribed oral anticoagulants | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …

A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants

S Halvorsen, W Ghanima, IF Tvete… - European Heart …, 2017 - search.proquest.com
A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being
prescribed oral anticoagulants Page 1 .................... A nationwide registry study to compare …

A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants

S Halvorsen, W Ghanima, IF Tvete… - European heart …, 2017 - pubmed.ncbi.nlm.nih.gov
Aims We aimed to evaluate bleeding risk in clinical practice in patients with atrial fibrillation
(AF) being prescribed dabigatran, rivaroxaban, or apixaban compared with warfarin …
[HTML] nih.gov

[HTML][HTML] A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants

S Halvorsen, W Ghanima, IF Tvete… - European Heart …, 2017 - ncbi.nlm.nih.gov
Aims We aimed to evaluate bleeding risk in clinical practice in patients with atrial fibrillation
(AF) being prescribed dabigatran, rivaroxaban, or apixaban compared with warfarin …

A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants.

S Halvorsen, W Ghanima, F Tvete… - European Heart …, 2016 - europepmc.org
Aims We aimed to evaluate bleeding risk in clinical practice in patients with atrial fibrillation
(AF) being prescribed dabigatran, rivaroxaban, or apixaban compared with warfarin …